CHINA GEWANG BIOTECHNOLOGY, INC. - Statements of Operations and Comprehensive Income - USD ($)	12 Months Ended
	Nov. 30, 2015	Nov. 30, 2014
Income Statement
Revenue	$ 4,184,255	$ 2,368,016
Cost of goods sold	(1,186,461)	(725,449)
Gross Profit	2,997,794	1,642,567
Operating expenses:
Selling and marketing	836,040	473,670
General and administrative	528,627	150,154
Total operating expenses	1,364,667	623,824
Operating income	1,633,127	1,018,743
Other income:
Interest income	13,508	2,900
Income before provision for income taxes	1,646,635	1,021,643
Provision for income taxes	457,922	264,553
Net income before noncontrolling interests	1,188,713	757,090
Noncontrolling interests	(61,790)	(38,952)
Net income attributable to common stockholders	$ 1,126,923	$ 718,138
Earnings per common share	$ 0.02	$ 0.02
Weighted average outstanding shares	40,944,444	35,500,000
Comprehensive income (loss):
Net income before noncontrolling interests	$ 1,188,713	$ 757,090
Foreign currency translation adjustment	(315,020)	1,333
Comprehensive (loss) income	873,693	758,423
Comprehensive (loss) income attributable to noncontrolling interest	46,039	39,019
Net comprehensive income attributable to common stockholders	$ 827,654	$ 719,404